Biopharmaceutical Company founded by Australian Nobel Laureate - Patented Product for Treatments of Allergy Indications

Categories:	Securities, Unissued Securities
Sale Type:	Price on Application
Price Guide:	AUD A$3.5M raise at A$0.05 per share - A$2.75M already raised (pre-money valuation of A$1.57M)
Status:	Closed

Summary:

Unlisted Australian company founded by Australian Nobel Laureate to develop and commercialise novel treatments in rapidly growing international market for allergic indications including childhood eczema, food allergies, allergic asthma. Funds required to complete pre-clinical studies and quality manufacture of patented product for use in animal safety studies and clinical trials.